Financials, Technology, Healthcare Dec 14, 2021 04:19 PM (GMT+8) · EqualOcean
Financial Associated Press, Dec. 14, Sinopharm announced that its wholly-owned subsidiary Sinopharm Rongsheng potassium chloride injection (10ml: 1.5g) obtained the notice of approval for drug supplement application and approved to increase the specification of 10ml: 1.5g. Its wholly-owned subsidiary Sinopharm Wichita obtained the registration certificate of lipoic acid API issued by the Ministry of health and family welfare of India and the Ministry of food and drug safety of South Korea respectively.
Related companies: